Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
United Therapeutic
(NQ:
UTHR
)
345.63
-4.38 (-1.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about United Therapeutic
< Previous
1
2
3
4
5
6
7
8
9
Next >
United Therapeutics Named by Newsweek as One of America’s Most Responsible Companies 2024
December 07, 2023
From
United Therapeutics Corporation
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC)
November 13, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
November 09, 2023
Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.
Via
InvestorPlace
United Therapeutics: A Strong Quarter But What About 2024?
August 15, 2023
United Therapeutics had strong Tyvaso sales but it highlights the investor debate heading into 2024.
Via
Talk Markets
What 4 Analyst Ratings Have To Say About United Therapeutics
August 03, 2023
Via
Benzinga
Flying Car Stocks: What a Devastating Short Report Means for EHang
November 08, 2023
Hindenburg raised red flags for flying car stocks after releasing a short report on EH stock. Here's what investors should watch.
Via
InvestorPlace
EH Stock Alert: Hindenburg Slams EHang in New Short Report
November 07, 2023
EH stock is falling back to earth after Hindenburg Research issued a short report on the electric vertical take-off and landing (eVTOL) firm.
Via
InvestorPlace
United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
November 01, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Announces First Patient Enrolled in Phase 3 TETON PPF Study of Nebulized Tyvaso in Patients with Progressive Pulmonary Fibrosis
October 31, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics's Return On Capital Employed Insights
May 10, 2023
Via
Benzinga
Earnings Scheduled For November 1, 2023
November 01, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion.
Via
Benzinga
United Therapeutics Corporation to Present at the UBS Biopharma Conference 2023
October 31, 2023
From
United Therapeutics Corporation
Via
Business Wire
Health Care Company United Therapeutics Announces Acquisition of Miromatrix Medical
October 30, 2023
Via
Benzinga
Why Is Life Sciences Company Miromatrix Medical Stock Trading Higher Today?
October 30, 2023
United Therapeutics Corporation (NASDAQ: UTHR) has agreed to acquire Miromatrix Medical Inc (NASDAQ: MIRO) for $3.25 per share in cash (an aggregate of approximately $91 million).
Via
Benzinga
Why Is Miromatrix Medical (MIRO) Stock Up 235% Today?
October 30, 2023
Miromatrix Medical stock is rocketing higher on Monday after the company reached an acquisition agreement with United Therapeutics for MIRO.
Via
InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
October 30, 2023
It's time to dive into the biggest pre-market stock movers as we start the trading week on Monday with the hottest coverage!
Via
InvestorPlace
United Therapeutics to Acquire Miromatrix Medical
October 30, 2023
From
Miromatrix Medical Inc.
Via
GlobeNewswire
United Therapeutics to Acquire Miromatrix Medical
October 30, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Report Third Quarter 2023 Financial Results Before the Market Opens on Wednesday, November 1, 2023
October 25, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Announces Recent Milestones for its Heart and Kidney Xenotransplantation Programs
September 22, 2023
From
United Therapeutics Corporation
Via
Business Wire
Bullet Proof Your Portfolio: 3 Must-Have Defensive Stocks for 2023
September 20, 2023
Defensive stocks have always been the go-to investments for those looking to protect their long-term portfolio and weather downturns.
Via
InvestorPlace
United Therapeutics Issues its 2023 Corporate Responsibility and Public Benefit Report
September 12, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Corporation to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 01, 2023
From
United Therapeutics Corporation
Via
Business Wire
The 3 Most Undervalued Biotech Stocks to Buy Now: August 2023
August 17, 2023
This article points you to three undervalued biotech stocks that have the potential to deliver stellar returns for patient investors.
Via
InvestorPlace
United Therapeutics Corporation Reports Second Quarter 2023 Financial Results
August 02, 2023
From
United Therapeutics Corporation
Via
Business Wire
If You Can Only Buy One Biotech Stock, It Better Be One of These 3 Names
July 26, 2023
These are the best biotech stocks that investors can invest in. That's because they are sector leaders that can make you a millionaire.
Via
InvestorPlace
United Therapeutics Corporation to Report Second Quarter 2023 Financial Results Before the Market Opens on Wednesday, August 2, 2023
July 26, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation
July 24, 2023
From
United Therapeutics Corporation
Via
Business Wire
United Therapeutics Unveils Net Zero Energy Distribution Center
June 14, 2023
From
United Therapeutics Corporation
Via
Business Wire
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
May 18, 2023
These two mid-cap biotech companies are relatively established in their fields — but according to analysts, still have significant upside.
Via
MarketBeat
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.